EPZM Epizyme Inc

Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.

$2.94  -0.16 (-5.16%)
As of 12/03/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/31/2013
Outstanding shares:  103,895,022
Average volume:  1,612,861
Market cap:   $322,074,568
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29428V104
ISIN:        US29428V1044
Sedol:      B9Z1QZ7
Valuation   (See tab for details)
PE ratio:   -1.14
PB ratio:   9.51
PS ratio:   9.41
Return on equity:   -1,734.10%
Net income %:   -779.45%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy